Metabolic reprogramming in liver fibrosis.

Area of Science:

• Hepatology
• Cellular Metabolism
• Molecular Biology

Background:

• Chronic liver diseases, including metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol use, and viral hepatitis, can progress to fibrosis, cirrhosis, and cancer.
• Hepatic fibrogenesis involves complex cellular interactions leading to extracellular matrix deposition and organ failure.

Purpose of the Study:

• To explore the role of metabolic adaptations in liver fibrosis.
• To identify potential therapeutic targets for halting or reversing liver fibrosis progression.

Main Methods:

• Analysis of transcriptional and protein synthesis changes in liver cells.
• Investigation of cellular substrate metabolism, including glucose and lipid metabolism.
• Examination of metabolic stress responses and signaling pathways.

Main Results:

• Cellular metabolic shifts, resembling the Warburg effect, are observed during liver fibrosis.
• Metabolic adaptations are crucial for the activation of macrophages, lymphoid cells, and hepatic stellate cells.
• Metabolic stress responses regulate cell activation and fibrogenic processes.

Conclusions:

• Metabolic adaptations are integral to liver fibrosis pathogenesis.
• Targeting metabolic pathways presents a promising therapeutic strategy for liver diseases.
• Interventions modulating these pathways may halt or reverse liver fibrosis.